ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $44,000 | -18.5% | 34,026 | -13.2% | 0.00% | – |
| Q1 2021 | $54,000 | -28.0% | 39,186 | +105.2% | 0.00% | – |
| Q3 2019 | $75,000 | -21.9% | 19,096 | -19.5% | 0.00% | – |
| Q2 2019 | $96,000 | -56.6% | 23,719 | -24.4% | 0.00% | – |
| Q1 2019 | $221,000 | +37.3% | 31,386 | +6.3% | 0.00% | – |
| Q4 2018 | $161,000 | -52.9% | 29,521 | -7.3% | 0.00% | – |
| Q3 2018 | $342,000 | -15.8% | 31,836 | +2.2% | 0.00% | – |
| Q2 2018 | $406,000 | +259.3% | 31,137 | +205.8% | 0.00% | – |
| Q1 2018 | $113,000 | +10.8% | 10,183 | +0.0% | 0.00% | – |
| Q4 2017 | $102,000 | – | 10,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |